Credit Rating Downgrades Hitting Dozens Of Health Systems
Current challenging operating environments are blamed. Separate reports show there's an "exodus" of life scientists from academia to industry positions, raising worries over the future of U.S. science. Other news includes new drug reviews and approvals, an Eli Lilly whistleblower lawsuit and more.